SCHEMBL3455675

SCHEMBL3455675

C1=CC(C2CCNCC2)NC=C1c1ccc(N2CCOCC2)cc1

nearest known ligand 0.34

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 1/20 0.34
MELK Q14680 1/20 0.34
PDE3B Q13370 2/20 0.34
PDE3A Q14432 2/20 0.34
MAPT P10636 4/20 0.33
ALDH1A1 P00352 4/20 0.33
MEN1 O00255 2/20 0.33
HTT P42858 2/20 0.33
KMT2A Q03164 2/20 0.33
NPC1 O15118 2/20 0.33
RAB9A P51151 2/20 0.33
SYK P43405 1/20 0.33
CYP1A2 P05177 1/20 0.33
CNR2 P34972 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM1 P11229 1/20 0.33
CHRM3 P20309 1/20 0.33
KDM4E B2RXH2 4/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3464721 0.84 PIK3CA (0.35) LRRK2PDE3BPDE3AMAPTALDH1A1
SCHEMBL3067369 0.74 MAPT (0.34) LRRK2MELKPDE3BPDE3AMAPT
SCHEMBL19139501 0.67 SIGMAR1 (0.48) LRRK2MAPTALDH1A1MEN1HTT
SCHEMBL7082120 0.67 ADRB1 (0.63) MAPTALDH1A1MEN1HTTKMT2A
Hydrochloric Acid SCHEMBL28769210 0.65 ADRB1 (0.61) MAPTALDH1A1MEN1HTTKMT2A
Bromide SCHEMBL6539744 0.65 ADRB1 (0.61) MAPTALDH1A1MEN1HTTKMT2A
SCHEMBL23410248 0.64 HRH1 (0.53) LRRK2MAPTALDH1A1MEN1HTT
SCHEMBL27569317 0.64 GBA1 (0.53) LRRK2MELKMAPTALDH1A1MEN1
SCHEMBL3065789 0.63 JAK2 (0.48) LRRK2MELKMAPTNPC1RAB9A
Hydrochloric Acid SCHEMBL4767983 0.62 GBA1 (0.51) LRRK2MELKMAPTALDH1A1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2166850-A1 NEW HETEOCYCLIC H3 ANTAGONISTS High Point Pharmaceuticals, LLC (US) 2010-03-31 EP disclosed
WO-2008154126-A1 NEW HETEOCYCLIC H3 ANTAGONISTS HIGH POINT PHARMACEUTICALS, LLC (US) 2008-12-18 WO disclosed